
|Podcasts|April 23, 2021
Podcast: First drug-eluting contact lens approved in Japan
Acuvue Theravision with Ketotifen from Johnson & Johnson Vision is the first entry into an anticipated category of drug-eluting contact lenses.
Advertisement
Acuvue Theravision with Ketotifen from Johnson & Johnson Vision is the first entry into an anticipated category of drug-eluting contact lenses. This lens was recently approved in Japan for vision correction and allergy symptom relief. Brian Pall, OD, MS, FAAO, director of clinical science at Johnson & Johnson Vision Care, discusses the lens and its technology.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Simplifying the treatment of ocular surface disease
2
Lab-grown retinal cells restore vasculature in mouse studies
3
i-Lumen Scientific enrolls first US patient in i-SIGHT2 pivotal trial of i-Lumen AMD System
4
Glaucoma treatment rates climb in New Zealand, disparities persist for Mฤori and Pasifika patients
5






















